ReviewMolecules (Basel, Switzerland)2025
Fullerene-Supported Single-Atom Catalysts for Electrocatalytic Water Splitting: Progress, Challenges, and Machine Learning Perspectives.
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fullerene-supported single-atom catalysts (SACs) have emerged as a promising class of materials for electrocatalytic overall water splitting, offering a route to reduce reliance on scarce and costly precious metals. This review systematically summarizes recent advances in the design, synthesis, and application of fullerene-based SACs, with an emphasis on their unique structural, electronic, and catalytic properties. The exceptional stability, conductivity, and surface chemistry of fullerenes enable strong interactions with metal atoms, allowing high dispersion and enhanced catalytic performance for both the hydrogen evolution reaction (HER) and oxygen evolution reaction (OER). Recent studies demonstrate that C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.